{
    "organizations": [],
    "uuid": "b1e114136657cb027767a0fdb973de8f61aa1b47",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-fujian-cosunter-pharmaceutical-see/brief-fujian-cosunter-pharmaceutical-sees-fy-2017-net-profit-down-44-3-pct-to-59-4-pct-idUSL4N1PO388",
    "ord_in_thread": 0,
    "title": "BRIEF-Fujian Cosunter Pharmaceutical sees FY 2017 net profit down 44.3 pct to 59.4 pct",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 29(Reuters) - Fujian Cosunter Pharmaceutical Co Ltd\n* Sees FY 2017 net profit to decrease by 44.3 percent to 59.4 percent, or to be 27 million yuan to 37 million yuan\n* Says FY 2016 net profit was 66.4 million yuan\n* Says decreased operating revenue and increased R&D investment are the main reasons for the forecast\nSource text in Chinese: goo.gl/jkJT2u\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-01-29T17:08:00.000+02:00",
    "crawled": "2018-01-30T18:51:17.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "fujian",
        "cosunter",
        "pharmaceutical",
        "co",
        "ltd",
        "see",
        "fy",
        "net",
        "profit",
        "decrease",
        "percent",
        "percent",
        "million",
        "yuan",
        "million",
        "yuan",
        "say",
        "fy",
        "net",
        "profit",
        "million",
        "yuan",
        "say",
        "decreased",
        "operating",
        "revenue",
        "increased",
        "r",
        "investment",
        "main",
        "reason",
        "forecast",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}